Literature DB >> 19131156

S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.

Mei-Hong Li1, Teresa Sanchez, Harold Yamase, Timothy Hla, Myat Lin Oo, Anna Pappalardo, Kevin R Lynch, Chen-Yong Lin, Fernando Ferrer.   

Abstract

Sphingosine-1-phosphate (S1P) is an important regulator of cellular functions via interaction with its receptors S1P(1-5). To date, nothing is known about the S1P receptor expression and the effects of S1P signaling in Wilms tumor. In this study, we found ubiquitous expression of S1P receptors in Wilms tumor specimens and cell lines. We demonstrated that S1P(1) acted as a promigratory modulator by employing S1P(1) antagonist VPC44116, S1P(1) siRNA and adenoviral transduction in Wilms tumor cells. Further, we clarified that S1P(1)-mediated migration occurred via Gi coupling and activation of PI3K and Rac1. In addition, S1P stimulated WiT49 cell invasion through S1P(1)/Gi signaling pathway. We consider that targeting S1P(1) may be a point of therapeutic intervention in Wilms tumor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131156      PMCID: PMC2943759          DOI: 10.1016/j.canlet.2008.11.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  36 in total

1.  Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins.

Authors:  J H Paik; M J Lee; S Thangada; T Hla
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

Review 2.  Lysophospholipids--receptor revelations.

Authors:  T Hla; M J Lee; N Ancellin; J H Paik; M J Kluk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

3.  Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

Authors:  M J Lee; S Thangada; K P Claffey; N Ancellin; C H Liu; M Kluk; M Volpi; R I Sha'afi; T Hla
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

4.  Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.

Authors:  Teresa Sanchez; Athanasia Skoura; Ming Tao Wu; Brian Casserly; Elizabeth O Harrington; Timothy Hla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-04-12       Impact factor: 8.311

5.  Late effects in children treated with radiation therapy for Wilms' tumor.

Authors:  A C Paulino; B C Wen; C K Brown; R Tannous; N A Mayr; W K Zhen; G J Weidner; D H Hussey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

6.  Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group.

Authors:  Daniel M Green; Eve M Peabody; Bin Nan; Susan Peterson; John A Kalapurakal; Norman E Breslow
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

7.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

8.  Osteopenia in survivors of Wilms tumor.

Authors:  Fahad Othman; Chun-Yuan Guo; Colin Webber; Stephanie A Atkinson; Ronald D Barr
Journal:  Int J Oncol       Date:  2002-04       Impact factor: 5.650

9.  Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.

Authors:  James R Van Brocklyn; Nicholas Young; Rosemary Roof
Journal:  Cancer Lett       Date:  2003-09-10       Impact factor: 8.679

10.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

View more
  33 in total

1.  Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.

Authors:  Wen Hui Lin; Janet L Martin; Deborah J Marsh; Michelle M Jack; Robert C Baxter
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

2.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

3.  Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.

Authors:  Cheng-Fan Lee; Andrew Dang; Elizabeth Hernandez; Rey-Chen Pong; Benjamin Chen; Rajni Sonavane; Ganesh Raj; Payal Kapur; Hsin-Ying Lin; Shang-Ru Wu; Chun-Jung Ko; U-Ging Lo; Hsin-Yu Lee; Jer-Tsong Hsieh; Ming-Shyue Lee
Journal:  Oncogene       Date:  2019-05-31       Impact factor: 9.867

Review 4.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

5.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 6.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

7.  Sphingolipid modulation of angiogenic factor expression in neuroblastoma.

Authors:  Mei-Hong Li; Timothy Hla; Fernando Ferrer
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-16

8.  Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma.

Authors:  Mei-Hong Li; Miriam Harel; Timothy Hla; Fernando Ferrer
Journal:  J Pediatr Surg       Date:  2014-05-16       Impact factor: 2.545

9.  FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.

Authors:  Mei-Hong Li; Timothy Hla; Fernando Ferrer
Journal:  Pediatr Blood Cancer       Date:  2013-05-23       Impact factor: 3.167

Review 10.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.